The 4N cell cycle delay in Fanconi anemia reflects growth arrest in late S phase.

被引:55
作者
Akkari, YMN
Bateman, RL
Reifsteck, CA
D'Andrea, AD
Olson, SB
Grompe, M
机构
[1] Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Pediat Oncol, Boston, MA 02115 USA
关键词
Fanconi anemia; interstrand DNA crosslink; Fanconi anemia group A; Fanconi anemia group C;
D O I
10.1006/mgme.2001.3259
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fanconi anemia (FA) is a human genetic disorder characterized by hypersensitivity to DNA crosslinking agents. Its cellular phenotypes include increased chromosome breakage and a marked cell-cycle delay with 4N DNA content after introduction of interstrand DNA crosslinks (ICL). To further understand the nature of this delay previously described as a G2/M arrest, we introduced ICL specifically during G2 and monitored the cells for passage into mitosis. Our results showed that, even at the highest doses, postreplication ICL produced neither G2/M arrest nor chromosome breakage in FA-A or FA-C cells. This suggests that, similar to wild-type cells, DNA replication is required to trigger both responses. Therefore, the 4N cell DNA content observed in FA cells after ICL treatment also represents incomplete DNA replication and arrest in late S phase. FA fibroblasts from complementation groups A and C were able to recover from the ICL-induced cell-cycle arrest, but took similar to3 times longer than controls. These results indicate that the FA pathway is required for the efficient resolution of ICL-induced S-phase arrest. (C) 2001 Elsevier Science.
引用
收藏
页码:403 / 412
页数:10
相关论文
共 55 条
  • [1] DNA replication is required to elicit cellular responses to psoralen-induced DNA interstrand cross-links
    Akkari, YMN
    Bateman, RL
    Reifsteck, CA
    Olson, SB
    Grompe, M
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (21) : 8283 - 8289
  • [2] Positional cloning of the Fanconi anaemia group A gene
    Apostolou, S
    Whitmore, SA
    Crawford, J
    Lennon, G
    Sutherland, GR
    Callen, DF
    Ianzano, L
    Savino, M
    DApolito, M
    Notarangelo, A
    Memeo, E
    Piemontese, MR
    Zelante, L
    Savoia, A
    Gibson, RA
    Tipping, AJ
    Morgan, NV
    Hassock, S
    Jansen, S
    deRavel, TJ
    VanBerkel, C
    Pronk, JC
    Easton, DF
    Mathew, CG
    Levran, O
    Verlander, PC
    Batish, SD
    Erlich, T
    Auerbach, AD
    CletonJansen, AM
    Moerland, EW
    Cornelisse, CJ
    Doggett, NA
    Deaven, LL
    Moyzis, RK
    [J]. NATURE GENETICS, 1996, 14 (03) : 324 - 328
  • [3] AUERBACH AD, 2001, METABOLIC MOL BASIS, P753
  • [4] BAGNARA GP, 1992, BLOOD, V80, P382
  • [5] ANGELICINS, ANGULAR ANALOGS OF PSORALENS - CHEMISTRY, PHOTOCHEMICAL, PHOTOBIOLOGICAL AND PHOTOTHERAPEUTIC PROPERTIES
    BORDIN, F
    DALLACQUA, F
    GUIOTTO, A
    [J]. PHARMACOLOGY & THERAPEUTICS, 1991, 52 (03) : 331 - 363
  • [6] MUTATIONAL RESPONSE OF FANCONI-ANEMIA CELLS TO SHUTTLE VECTOR SITE-SPECIFIC PSORALEN CROSS-LINKS
    BREDBERG, A
    SANDOR, Z
    BRANT, M
    [J]. CARCINOGENESIS, 1995, 16 (03) : 555 - 561
  • [7] BUCHWALD M, 1992, CLONING FANCONI ANEM, P19
  • [8] Damage-resistant DNA synthesis in Fanconi anemia cells treated with a DNA gross-linking agent
    Centurion, SA
    Kuo, HR
    Lambert, WC
    [J]. EXPERIMENTAL CELL RESEARCH, 2000, 260 (02) : 216 - 221
  • [9] The sensitivity of Fanconi anaemia group C cells to apoptosis induced by mitomycin C is due to oxygen radical generation, not DNA crosslinking
    Clarke, AA
    Philpott, NJ
    GordonSmith, EC
    Rutherford, TR
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1997, 96 (02) : 240 - 247
  • [10] CLEAVER JE, 1984, NATL CANCER I MONOGR, V66, P137